ifenprodil has been researched along with Disease Models, Animal in 38 studies
ifenprodil: NMDA receptor antagonist
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effect of rostral anterior cingulate cortex (rACC) administration with ifenprodil (NR2B receptor blocker) on bone cancer pain (BCP)-related aversion sentiment using the conditioned place avoidance experiments in rats." | 7.83 | Effect of the ifenprodil administered into rostral anterior cingulate cortex on pain-related aversion in rats with bone cancer pain. ( Chen, Z; Feng, H; Liu, Z; Wang, G; Zhao, X, 2016) |
| "To explore the effects of mild hypothermia combined with ifenprodil on the survival of neuronal and translocation of apoptosis inducing factor (AIF) following global cerebral ischemia-reperfusion to understand the mechanism of combination in cerebral resuscitation." | 7.80 | [Effects of mild hypothermia plus ifenprodil on apoptosis inducing factor translocation after global cerebral ischemia-reperfusion in rats]. ( Duan, M; Gao, W; Hui, K; Xu, J; Xu, M; Zeng, Q; Zhou, Y; Zou, Y, 2014) |
| "Ifenprodil reduces CA-elicited brain edema." | 7.72 | Effect of ifenprodil, a polyamine site NMDA receptor antagonist, on brain edema formation following asphyxial cardiac arrest in rats. ( Alexander, JS; Arnold, T; Carden, D; Conrad, S; Monroe, J; Pardue, S; Sharp, CD; Turnage, R; Xiao, F, 2004) |
| "Ifenprodil was encapsulated into liposomes by a remote loading method using pH gradient between internal and external water phases of liposomes, focusing on differences of its solubility in water depending on pH." | 5.51 | Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions. ( Agato, Y; Asai, T; Fukuta, T; Ishii, T; Kikuchi, T; Koide, H; Oku, N; Shimizu, K; Yanagida, Y, 2019) |
| "Ifenprodil (20 mg/kg) was administered intraperitoneally (ip) after the stimulation with 3." | 5.48 | Does status epilepticus modify the effect of ifenprodil on cortical epileptic afterdischarges in immature rats? ( Abbasova, K; Kubová, H; Mareš, P, 2018) |
| "To assess the effect of rostral anterior cingulate cortex (rACC) administration with ifenprodil (NR2B receptor blocker) on bone cancer pain (BCP)-related aversion sentiment using the conditioned place avoidance experiments in rats." | 3.83 | Effect of the ifenprodil administered into rostral anterior cingulate cortex on pain-related aversion in rats with bone cancer pain. ( Chen, Z; Feng, H; Liu, Z; Wang, G; Zhao, X, 2016) |
| "To explore the effects of mild hypothermia combined with ifenprodil on the survival of neuronal and translocation of apoptosis inducing factor (AIF) following global cerebral ischemia-reperfusion to understand the mechanism of combination in cerebral resuscitation." | 3.80 | [Effects of mild hypothermia plus ifenprodil on apoptosis inducing factor translocation after global cerebral ischemia-reperfusion in rats]. ( Duan, M; Gao, W; Hui, K; Xu, J; Xu, M; Zeng, Q; Zhou, Y; Zou, Y, 2014) |
| "To assess the neuroprotective effects of different glutamate modulation strategies, with a nonselective (MK801) and a selective (ifenprodil) NMDA receptor antagonist and a metabotropic glutamate receptor agonist (mGluR Group II, LY354740), in glaucoma-related in vivo rat models of retinal ganglion cell (RGC) apoptosis." | 3.73 | Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. ( Cordeiro, MF; Fitzke, FW; Guo, L; Luong, V; Maass, A; Moss, SE; Salt, TE, 2006) |
| "Ifenprodil reduces CA-elicited brain edema." | 3.72 | Effect of ifenprodil, a polyamine site NMDA receptor antagonist, on brain edema formation following asphyxial cardiac arrest in rats. ( Alexander, JS; Arnold, T; Carden, D; Conrad, S; Monroe, J; Pardue, S; Sharp, CD; Turnage, R; Xiao, F, 2004) |
| "Ifenprodil was encapsulated into liposomes by a remote loading method using pH gradient between internal and external water phases of liposomes, focusing on differences of its solubility in water depending on pH." | 1.51 | Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions. ( Agato, Y; Asai, T; Fukuta, T; Ishii, T; Kikuchi, T; Koide, H; Oku, N; Shimizu, K; Yanagida, Y, 2019) |
| "Ifenprodil treatment for both doses showed anti-allodynic and anti-nociceptive effects with lower expression of phosphorylated and total spinal NR2B." | 1.51 | Increased Nociceptive Responses in Streptozotocin-Induced Diabetic Rats and the Related Expression of Spinal NR2B Subunit of ( Abd Aziz, CB; Haris, K; Ismail, CAN; Long, I; Suppian, R, 2019) |
| "Ifenprodil (20 mg/kg) was administered intraperitoneally (ip) after the stimulation with 3." | 1.48 | Does status epilepticus modify the effect of ifenprodil on cortical epileptic afterdischarges in immature rats? ( Abbasova, K; Kubová, H; Mareš, P, 2018) |
| "Spermine protects against LPS-induced memory deficits in mice by a mechanism that involves GluN2B receptors." | 1.42 | Spermine reverses lipopolysaccharide-induced memory deficit in mice. ( Duarte, T; Frühauf, PK; Ineu, RP; Mello, CF; Rubin, MA; Tomazi, L, 2015) |
| "Panic attacks are a hallmark in panic disorder (PAND)." | 1.39 | Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model. ( Amador-Arjona, A; D'Amico, D; Dierssen, M; Santos, M; Spadoni, O; Stork, O, 2013) |
| "Using models of acute and chronic seizures in C57BL/6 mice, we discovered a proconvulsant pathway involving high-mobility group box-1 (HMGB1) release from neurons and glia and its interaction with Toll-like receptor 4 (TLR4), a key receptor of innate immunity." | 1.36 | Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. ( Aronica, E; Balosso, S; Bianchi, ME; Casalgrandi, M; Iyer, AM; Liu, J; Manfredi, AA; Maroso, M; Molteni, M; Ravizza, T; Rossetti, C; Vezzani, A, 2010) |
| "Mechanical hyperalgesia was clearly observed during ethanol consumption and even after ethanol withdrawal, and lasted for 14 weeks." | 1.34 | Changes in function of NMDA receptor NR2B subunit in spinal cord of rats with neuropathy following chronic ethanol consumption. ( Miyoshi, K; Narita, M; Suzuki, T, 2007) |
| "The decrease in the seizure threshold for pentylenetetrazole during diazepam withdrawal was inhibited by pretreatment with MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cycloheptan-5,10-imine maleate), 7-chlorokynurenic acid and ifenprodil." | 1.30 | Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists. ( Misawa, M; Suzuki, T; Tsuda, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.26) | 18.2507 |
| 2000's | 14 (36.84) | 29.6817 |
| 2010's | 20 (52.63) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Kikuchi, T | 1 |
| Fukuta, T | 1 |
| Agato, Y | 1 |
| Yanagida, Y | 1 |
| Ishii, T | 1 |
| Koide, H | 1 |
| Shimizu, K | 1 |
| Oku, N | 1 |
| Asai, T | 1 |
| Liu, Z | 2 |
| Yu, Z | 1 |
| Yu, S | 1 |
| Zhu, C | 1 |
| Dong, M | 1 |
| Mao, W | 1 |
| Hu, J | 1 |
| Prorok, M | 1 |
| Su, R | 1 |
| Dai, Q | 1 |
| Okuda, K | 1 |
| Kobayashi, S | 1 |
| Fukaya, M | 1 |
| Watanabe, A | 1 |
| Murakami, T | 1 |
| Hagiwara, M | 1 |
| Sato, T | 1 |
| Ueno, H | 1 |
| Ogonuki, N | 1 |
| Komano-Inoue, S | 1 |
| Manabe, H | 1 |
| Yamaguchi, M | 1 |
| Ogura, A | 1 |
| Asahara, H | 1 |
| Sakagami, H | 1 |
| Mizuguchi, M | 1 |
| Manabe, T | 1 |
| Tanaka, T | 1 |
| Schidlitzki, A | 1 |
| Twele, F | 1 |
| Klee, R | 1 |
| Waltl, I | 1 |
| Römermann, K | 1 |
| Bröer, S | 1 |
| Meller, S | 1 |
| Gerhauser, I | 1 |
| Rankovic, V | 1 |
| Li, D | 2 |
| Brandt, C | 1 |
| Bankstahl, M | 1 |
| Töllner, K | 1 |
| Löscher, W | 1 |
| Abbasova, K | 1 |
| Kubová, H | 1 |
| Mareš, P | 1 |
| Ismail, CAN | 1 |
| Suppian, R | 1 |
| Abd Aziz, CB | 1 |
| Haris, K | 1 |
| Long, I | 1 |
| Abushik, PA | 1 |
| Sibarov, DA | 1 |
| Eaton, MJ | 1 |
| Skatchkov, SN | 1 |
| Antonov, SM | 1 |
| Santos, M | 1 |
| D'Amico, D | 1 |
| Spadoni, O | 1 |
| Amador-Arjona, A | 1 |
| Stork, O | 1 |
| Dierssen, M | 1 |
| Huo, XL | 1 |
| Min, JJ | 1 |
| Pan, CY | 1 |
| Zhao, CC | 1 |
| Pan, LL | 1 |
| Gui, FF | 1 |
| Jin, L | 1 |
| Wang, XT | 1 |
| Gutierrez-Vargas, JA | 1 |
| Muñoz-Manco, JI | 1 |
| Garcia-Segura, LM | 1 |
| Cardona-Gómez, GP | 1 |
| Zou, Y | 1 |
| Zhou, Y | 1 |
| Gao, W | 1 |
| Zeng, Q | 1 |
| Hui, K | 1 |
| Xu, M | 1 |
| Duan, M | 1 |
| Xu, J | 1 |
| Poleszak, E | 1 |
| Wośko, S | 1 |
| Serefko, A | 1 |
| Wlaź, A | 1 |
| Kasperek, R | 1 |
| Dudka, J | 1 |
| Wróbel, A | 1 |
| Nowak, G | 1 |
| Wlaź, P | 1 |
| Frühauf, PK | 1 |
| Ineu, RP | 1 |
| Tomazi, L | 1 |
| Duarte, T | 1 |
| Mello, CF | 1 |
| Rubin, MA | 1 |
| Chen, B | 1 |
| Feng, B | 1 |
| Tang, Y | 1 |
| You, Y | 1 |
| Wang, Y | 1 |
| Hou, W | 1 |
| Hu, W | 1 |
| Chen, Z | 2 |
| Feng, H | 1 |
| Wang, G | 1 |
| Zhao, X | 1 |
| Huang, Y | 1 |
| Shen, W | 1 |
| Su, J | 1 |
| Cheng, B | 1 |
| Liu, G | 1 |
| Zhou, WX | 1 |
| Zhang, YX | 1 |
| Schumann, J | 1 |
| Yaka, R | 1 |
| Maroso, M | 1 |
| Balosso, S | 1 |
| Ravizza, T | 1 |
| Liu, J | 1 |
| Aronica, E | 1 |
| Iyer, AM | 1 |
| Rossetti, C | 1 |
| Molteni, M | 1 |
| Casalgrandi, M | 1 |
| Manfredi, AA | 1 |
| Bianchi, ME | 1 |
| Vezzani, A | 1 |
| Tallaksen-Greene, SJ | 1 |
| Janiszewska, A | 1 |
| Benton, K | 1 |
| Ruprecht, L | 1 |
| Albin, RL | 1 |
| Milnerwood, AJ | 1 |
| Kaufman, AM | 1 |
| Sepers, MD | 1 |
| Gladding, CM | 1 |
| Zhang, L | 1 |
| Wang, L | 1 |
| Fan, J | 1 |
| Coquinco, A | 1 |
| Qiao, JY | 1 |
| Lee, H | 1 |
| Wang, YT | 1 |
| Cynader, M | 1 |
| Raymond, LA | 1 |
| Di Maio, R | 1 |
| Mastroberardino, PG | 1 |
| Hu, X | 1 |
| Montero, LM | 1 |
| Greenamyre, JT | 1 |
| Richter, A | 1 |
| Morrison, LD | 1 |
| Galvan, CD | 1 |
| Wenzel, JH | 1 |
| Dineley, KT | 1 |
| Lam, TT | 1 |
| Schwartzkroin, PA | 1 |
| Sweatt, JD | 1 |
| Swann, JW | 1 |
| Tadano, T | 1 |
| Hozumi, S | 1 |
| Yamadera, F | 1 |
| Murata, A | 1 |
| Niijima, F | 1 |
| Tan-No, K | 1 |
| Nakagawasai, O | 1 |
| Kisara, K | 1 |
| Xiao, F | 1 |
| Pardue, S | 1 |
| Arnold, T | 1 |
| Carden, D | 1 |
| Alexander, JS | 1 |
| Monroe, J | 1 |
| Sharp, CD | 1 |
| Turnage, R | 1 |
| Conrad, S | 1 |
| Kirby, BP | 1 |
| Shaw, GG | 1 |
| Calcagnotto, ME | 1 |
| Baraban, SC | 1 |
| Gogas, KR | 1 |
| Guo, L | 1 |
| Salt, TE | 1 |
| Maass, A | 1 |
| Luong, V | 1 |
| Moss, SE | 1 |
| Fitzke, FW | 1 |
| Cordeiro, MF | 1 |
| Bandyopadhyay, S | 1 |
| Hablitz, JJ | 2 |
| Narita, M | 2 |
| Miyoshi, K | 1 |
| Suzuki, T | 2 |
| Iwata, H | 1 |
| Takasusuki, T | 1 |
| Yamaguchi, S | 1 |
| Hori, Y | 1 |
| Ding, S | 1 |
| Fellin, T | 1 |
| Zhu, Y | 1 |
| Lee, SY | 1 |
| Auberson, YP | 1 |
| Meaney, DF | 1 |
| Coulter, DA | 1 |
| Carmignoto, G | 1 |
| Haydon, PG | 1 |
| Fraser, CM | 1 |
| Cooke, MJ | 1 |
| Fisher, A | 1 |
| Thompson, ID | 1 |
| Stone, TW | 1 |
| Tsuda, M | 1 |
| Misawa, M | 1 |
| DeFazio, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Triple-blind Placebo Controlled Trial of Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival and Neurological Outcome[NCT04009759] | Phase 1 | 240 participants (Anticipated) | Interventional | 2021-10-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ifenprodil and Disease Models, Animal
| Article | Year |
|---|---|
Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Ant | 2006 |
37 other studies available for ifenprodil and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Suppression of Cerebral Ischemia/Reperfusion Injury by Efficient Release of Encapsulated Ifenprodil From Liposomes Under Weakly Acidic pH Conditions.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Disease Models, Animal; Hydrogen-Ion Concentrat | 2019 |
A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.
Topics: Animals; Conotoxins; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Locomot | 2021 |
CDKL5 controls postsynaptic localization of GluN2B-containing NMDA receptors in the hippocampus and regulates seizure susceptibility.
Topics: Animals; Disease Models, Animal; Disease Susceptibility; Excitatory Amino Acid Antagonists; Guanylat | 2017 |
A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy.
Topics: Animals; Anticonvulsants; Dentate Gyrus; Disease Models, Animal; Drug Administration Schedule; Drug | 2017 |
Does status epilepticus modify the effect of ifenprodil on cortical epileptic afterdischarges in immature rats?
Topics: Age Factors; Animals; Animals, Newborn; Anticonvulsants; Brain Waves; Cerebral Cortex; Disease Model | 2018 |
Increased Nociceptive Responses in Streptozotocin-Induced Diabetic Rats and the Related Expression of Spinal NR2B Subunit of
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disea | 2019 |
Kainate-induced calcium overload of cortical neurons in vitro: Dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain.
Topics: Adamantane; Animals; Calcium; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Disease Models, A | 2013 |
Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model.
Topics: Analysis of Variance; Animals; Bacterial Proteins; Conditioning, Classical; Disease Models, Animal; | 2013 |
Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Disease; Disease Models, Animal | 2014 |
GluN2B N-methyl-D-aspartic acid receptor subunit mediates atorvastatin-Induced neuroprotection after focal cerebral ischemia.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Cells, Cultured; Cerebral Cortex; D | 2014 |
[Effects of mild hypothermia plus ifenprodil on apoptosis inducing factor translocation after global cerebral ischemia-reperfusion in rats].
Topics: Animals; Apoptosis Inducing Factor; Brain Ischemia; Disease Models, Animal; Hypothermia, Induced; Ma | 2014 |
The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Synergism; Fluoxetine; Imip | 2014 |
Spermine reverses lipopolysaccharide-induced memory deficit in mice.
Topics: Analysis of Variance; Animals; Cytokines; Discrimination, Psychological; Disease Models, Animal; Dos | 2015 |
Blocking GluN2B subunits reverses the enhanced seizure susceptibility after prolonged febrile seizures with a wide therapeutic time-window.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Disease Susceptibility; Electroshock; Excitatory | 2016 |
Effect of the ifenprodil administered into rostral anterior cingulate cortex on pain-related aversion in rats with bone cancer pain.
Topics: Animals; Avoidance Learning; Bone Neoplasms; Cancer Pain; Conditioning, Psychological; Disease Model | 2016 |
Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
Topics: Amyloid beta-Peptides; Animals; Antimetabolites; Cycloserine; Disease Models, Animal; Excitatory Ami | 2017 |
Prolonged withdrawal from repeated noncontingent cocaine exposure increases NMDA receptor expression and ERK activity in the nucleus accumbens.
Topics: Analysis of Variance; Animals; Butadienes; Cocaine; Cocaine-Related Disorders; Disease Models, Anima | 2009 |
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Hippoc | 2010 |
Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Female; Huntington Disease; Kaplan-Meier Estimate; | 2010 |
Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Topics: Animals; Apoptosis; Cerebral Cortex; Coculture Techniques; Corpus Striatum; Disease Models, Animal; | 2012 |
Thiol oxidation and altered NR2B/NMDA receptor functions in in vitro and in vivo pilocarpine models: implications for epileptogenesis.
Topics: Acetylcysteine; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Dizocilpine Maleate; Ep | 2013 |
Polyamines in a genetic animal model of paroxysmal dyskinesia.
Topics: Aging; Animals; Brain; Case-Control Studies; Chorea; Cricetinae; Disease Models, Animal; Dose-Respon | 2003 |
Postsynaptic contributions to hippocampal network hyperexcitability induced by chronic activity blockade in vivo.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Anesthetics, Local; Animals; Animals, Newborn; Axons; Disease | 2003 |
Effects of NMDA receptor-related agonists on learning and memory impairment in olfactory bulbectomized mice.
Topics: 2-Amino-5-phosphonovalerate; Animals; Avoidance Learning; Cycloserine; Disease Models, Animal; Dizoc | 2004 |
Effect of ifenprodil, a polyamine site NMDA receptor antagonist, on brain edema formation following asphyxial cardiac arrest in rats.
Topics: Animals; Asphyxia; Brain Edema; Brain Ischemia; Cardiopulmonary Resuscitation; Disease Models, Anima | 2004 |
The neuroprotective effects of N1-dansyl-spermine in the gerbil model of cerebral ischaemia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Brain Ischemia; Cell Count; Dansy | 2004 |
Prolonged NMDA-mediated responses, altered ifenprodil sensitivity, and epileptiform-like events in the malformed hippocampus of methylazoxymethanol exposed rats.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interaction | 2005 |
Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
Topics: Animals; Apoptosis; Bridged Bicyclo Compounds; Disease Models, Animal; Dizocilpine Maleate; Dose-Res | 2006 |
NR2B antagonists restrict spatiotemporal spread of activity in a rat model of cortical dysplasia.
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Evoked Potentials; Neocortex; Patch-C | 2006 |
Changes in function of NMDA receptor NR2B subunit in spinal cord of rats with neuropathy following chronic ethanol consumption.
Topics: Alcohol Drinking; Animals; Chronic Disease; Disease Models, Animal; Ethanol; Hyperalgesia; Immunoblo | 2007 |
NMDA receptor 2B subunit-mediated synaptic transmission in the superficial dorsal horn of peripheral nerve-injured neuropathic mice.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Agents; Excitatory Postsyna | 2007 |
Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus.
Topics: Animals; Anticonvulsants; Astrocytes; Calcium; Calcium Signaling; Cell Death; Chelating Agents; Dise | 2007 |
Interactions between ifenprodil and dizocilpine on mouse behaviour in models of anxiety and working memory.
Topics: Animals; Anxiety; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Excitatory Amino A | 1996 |
Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists.
Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Disease Models, Animal; Dizocilpine Maleate; Drug I | 1997 |
Altered receptor subunit expression in rat neocortical malformations.
Topics: Animals; Disease Models, Animal; Epilepsy; Excitatory Postsynaptic Potentials; Freezing; Neocortex; | 2000 |